Update on Phototherapy in Jaundiced Neonates

Area of Science:

• Neonatal care
• Pediatric photobiology
• Bilirubin metabolism

Background:

• Jaundice in infants, particularly extremely low birth weight (ELBW) infants, can lead to neurodevelopmental impairment.
• Phototherapy is the standard treatment for neonatal hyperbilirubinemia.
• While rare in term infants, severe hyperbilirubinemia poses risks.

Purpose of the Study:

• To provide an updated overview of key aspects of phototherapy for infant jaundice.
• To discuss advancements in understanding phototherapy mechanisms and applications.

Main Methods:

• Analysis of bilirubin photoisomerization pathways under phototherapy.
• Review of light source efficacy, particularly comparing LEDs to traditional sources.
• Examination of clinical outcomes and safety concerns associated with phototherapy.

Main Results:

• Phototherapy converts bilirubin into excretable photoisomers (Z,E-bilirubin, E,Z-lumirubin).
• Efficient bilirubin reduction is achieved with light sources emitting at 460-490 nm; LEDs are recommended.
• Concerns exist regarding increased mortality in critically ill ELBW infants with prolonged phototherapy, though survivors may show reduced neurodevelopmental impairment.

Conclusions:

• Significant progress has been made in understanding phototherapy's mechanisms and practical use.
• LEDs represent an advancement in phototherapy light sources.
• Careful consideration of phototherapy duration and infant condition is crucial, especially for ELBW infants.